Cargando…
SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies are an excellent indicator of past COVID-19 infection. As the COVID-19 pandemic progresses, retained sensitivity over time is an important quality in an antibody assay that is to be used for the purpose of population seroprevale...
Autores principales: | Allen, Niamh, Brady, Melissa, Carrion Martin, Antonio Isidro, Domegan, Lisa, Walsh, Cathal, Houlihan, Elaine, Kerr, Colm, Doherty, Lorraine, King, Joanne, Doheny, Martina, Griffin, Damian, Molloy, Maria, Dunne, Jean, Crowley, Vivion, Holmes, Philip, Keogh, Evan, Naughton, Sean, Kelly, Martina, O’Rourke, Fiona, Lynagh, Yvonne, Crowley, Brendan, de Gascun, Cillian, Holder, Paul, Bergin, Colm, Fleming, Catherine, Ni Riain, Una, Conlon, Niall |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557912/ https://www.ncbi.nlm.nih.gov/pubmed/34585976 http://dx.doi.org/10.1128/Spectrum.00391-21 |
Ejemplares similares
-
Serological markers of SARS-CoV-2 infection; anti-nucleocapsid antibody positivity may not be the ideal marker of natural infection in vaccinated individuals
por: Allen, Niamh, et al.
Publicado: (2021) -
Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses
por: Allen, Niamh, et al.
Publicado: (2022) -
SARS-CoV-2 anti-nucleocapsid assay performance in healthcare workers at baseline and 6 months
por: Kerr, Colm, et al.
Publicado: (2021) -
SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations
por: McGrath, Jonathan, et al.
Publicado: (2023) -
Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity—lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices
por: McGrath, Jonathan, et al.
Publicado: (2023)